ID: ALA3770953
Chembl Id: CHEMBL3770953
PubChem CID: 127025404
Max Phase: Preclinical
Molecular Formula: C21H37NO4
Molecular Weight: 367.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCC(=O)C(=O)N1CCC[C@H]1C(=O)O
Standard InChI: InChI=1S/C21H37NO4/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-19(23)20(24)22-17-14-15-18(22)21(25)26/h18H,2-17H2,1H3,(H,25,26)/t18-/m0/s1
Standard InChI Key: FCTTVHGVDZEAOC-SFHVURJKSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 367.53 | Molecular Weight (Monoisotopic): 367.2723 | AlogP: 4.72 | #Rotatable Bonds: 15 |
| Polar Surface Area: 74.68 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 3.79 | CX Basic pKa: ┄ | CX LogP: 5.84 | CX LogD: 2.57 |
| Aromatic Rings: ┄ | Heavy Atoms: 26 | QED Weighted: 0.34 | Np Likeness Score: 0.07 |
| 1. Vasilakaki S, Barbayianni E, Leonis G, Papadopoulos MG, Mavromoustakos T, Gelb MH, Kokotos G.. (2016) Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations., 24 (8): [PMID:26970660] [10.1016/j.bmc.2016.02.040] |
Source(1):
